कोशिश गोल्ड - मुक्त
Does US cancer drug nod make Cipla attractive?
Mint Hyderabad
|April 18, 2025
Cipla, which makes HIV, respiratory and cancer drugs, is targeting North America with generic launches
Cipla Ltd's shares have surged 6% since last week when it announced the final approval from the US Food and Drug Administration for its generic version of Bristol Myers Squibb's Abraxane, a cancer drug. Does the approval to sell the much-awaited product in the US make Cipla a compelling buy, especially when Trump's tariffs loom?
"One product approval by itself doesn't suddenly make a company more attractive," said Prashant Nair, lead analyst for pharma and healthcare at Ambit Capital. "Earlier-than-expected approval for Abraxane is positive, but tariffs will have a bearing on Cipla."
यह कहानी Mint Hyderabad के April 18, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 9,500 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Hyderabad से और कहानियाँ
Mint Hyderabad
When street dogs, cats bring the office closer
When colleagues work towards a collective goal like looking after community animals, it offers them a sense of purpose
4 mins
September 15, 2025
Mint Hyderabad
US, Chinese officials hold talks in Spain
US and Chinese officials began talks in Madrid on Sunday on their strained trade ties, a looming divestiture deadline for Chinese short video app TikTok and Washington's demands that its allies place tariffs on China over its purchases of Russian oil.
1 min
September 15, 2025
Mint Hyderabad
Will We Disprove Yes Minister With Pension Reforms?
In Yes Minister, a TV satire on British politics, Sir Humphrey often stymied urgent reforms by setting up ‘interdepartmental committees.’
3 mins
September 15, 2025
Mint Hyderabad
It's Clear That Gamblers Should Pay More Taxes Than Investors
Investing aids the economy but gambling is simply consumption
3 mins
September 15, 2025
Mint Hyderabad
Q-comm gaming the grocery run
Platforms are leaning on gamification for marketing & retention
2 mins
September 15, 2025
Mint Hyderabad
Why Meme Marketers Hate Congratulations
With more budgets moving to influencer and meme marketing, it's sometimes hard to tell what is an ad and what isn't
4 mins
September 15, 2025
Mint Hyderabad
SonyLIV rolls with duel despite outrage
The broadcaster, streaming Asia Cup for first time, is sure of adding viewers, boosting revenue despite Indo-Pak tensions
2 mins
September 15, 2025
Mint Hyderabad
Govt alert on Cairo pharma payments
The Indian embassy in Cairo has issued a cautionary trade advisory to all Indian pharmaceutical exporters regarding Biomed For Pharmaceutical Industries, an Egyptian firm.
1 min
September 15, 2025
Mint Hyderabad
Digital loans against MFs are fast, but here's what you should know
Do not max out the LTV ratio, do not use it for long-term funding, and keep a watch on market volatility
5 mins
September 15, 2025
Mint Hyderabad
To curb smokeless tobacco use, India targets 100 high-burden districts
Consumption of smokeless tobacco, a leading cause for cancer, remains one of India's biggest public health challenges, with more than one in five people using such products.
2 mins
September 15, 2025
Listen
Translate
Change font size